152
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Trend of Mortality and Years of Life Lost Due to Chronic Obstructive Pulmonary Disease in China and Its Provinces, 2005–2020

ORCID Icon, , , , ORCID Icon, ORCID Icon, ORCID Icon, , , , , & show all
Pages 2973-2981 | Published online: 29 Oct 2021

References

  • Abbafati C, Abbas KM, Abbasi M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222. doi:10.1016/S0140-6736(20)30925-9
  • Yin P, Wang H, Vos T, et al. A subnational analysis of mortality and prevalence of COPD in China From 1990 to 2013 Findings From the Global Burden of Disease Study 2013. Chest. 2016;150(6):1269–1280. doi:10.1016/j.chest.2016.08.1474
  • Yin P, Feng X, Astell-Burt T, et al. Spatiotemporal variations in chronic obstructive pulmonary disease mortality in China: multilevel evidence from 2006 to 2012. COPD J Chronic Obstructive Pulmonary Dis. 2016;13(3):339–344. doi:10.3109/15412555.2015.1084613
  • Liu S, Wu X, Lopez AD, et al. An integrated national mortality surveillance system for death registration and mortality surveillance, China. Bull World Health Organ. 2016;94(1):46–57. doi:10.2471/blt.15.153148
  • Kang G, Peng Y, Lijun W, et al. Propensity score weighting for addressing under-reporting in mortality surveillance: a proof-of-concept study using the nationally representative mortality data in China. Popul Health Metr. 2015:13. doi:10.1186/s12963-015-0051-3
  • Wang Y, Li X, Zhou M, et al. Under-5 mortality in 2851 Chinese counties, 1996–2012: a subnational assessment of achieving MDG 4 goals in China. Lancet. 2016;387(10015):273–283. doi:10.1016/s0140-6736(15)00554-1
  • Wang H, Dwyer-Lindgren L, Lofgren KT, et al. Age-specific and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:9859. doi:10.1016/S0140-6736(12)61719-X
  • Naghavi M, Makela S, Foreman K, O’Brien J, Pourmalek F, Lozano R. Algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr. 2010;1:9. doi:10.1186/1478-7954-8-9
  • Wu S, Gona PN, Martinez G, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–1788. doi:10.1016/S0140-6736(18)32203-7
  • Department of Population and Employment & Statistics National Bureau of Statistics of China. China Population and Employment Statistics Yearbook 2011. Beijing: China Statistics Press; 2012.
  • Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–351. doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z
  • GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specifi c mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;389(10053):1459–1544. doi:10.1016/S0140-6736(16)31012-1
  • Das Gupta P. Standardization and Decomposition of Rates: A User’s Manual. Washington, DC: US Bureau of the Census; 1993.
  • World Health Organization. Noncommunicable diseases and mental health. NCD global Monitoring Framework [cited May 5, 2021.]; Available from: https://www.who.int/nmh/global_monitoring_framework/en/. Accessed October 20, 2021.
  • Ruvuna L, Sood A. Epidemiology of chronic obstructive pulmonary disease. Clin Chest Med. 2020;41(3):315–327. doi:10.1016/j.ccm.2020.05.002
  • National Center for Health Statistics. Chronic Obstructive Pulmonary Disease (COPD) includes: chronic bronchitis and emphysema; 2017. [cited 2021 February 21.]; Available from: https://www.cdc.gov/nchs/fastats/copd.htm. Accessed October 20, 2021.
  • Yip WC, Hsiao WC, Chen W, Hu S, Ma J, Maynard A. Early appraisal of China’s huge and complex health-care reforms. Lancet. 2012;1:833–842.
  • Wang C, Xu JY, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health CPH study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/s0140-6736(18)30841-9
  • Wang M, Luo X, Xu S, et al. Trends in smoking prevalence and implication for chronic diseases in China: serial national cross-sectional surveys from 2003 to 2013. Lancet Respir Med. 2018:35–45. doi:10.1016/S2213-2600(18)30432-6
  • Abbafati C, Abbas K, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020:1223–1249. doi:10.1016/S0140-6736(20)30752-2
  • Yin P, Brauer M, Cohen AJ, et al. The effect of air pollution on deaths, disease burden, and life expectancy across China and its provinces, 1990–2017: an analysis for the Global Burden of Disease Study 2017. Lancet Planetary Health. 2020;4(9):E386–E98. doi:10.1016/s2542-5196(20)30161-3
  • Syamlal G, Doney B, Mazurek JM. Chronic obstructive pulmonary disease prevalence among adults who have never smoked, by industry and occupation - United States, 2013–2017. MMWR Morbidity Mortality Weekly Rep. 2019;68(13):303–307. doi:10.15585/mmwr.mm6813a2
  • Tan WC, Ng TP. COPD in Asia: where East meets West. Chest. 2008;133(2):517–527. doi:10.1378/chest.07-1131
  • National Bureau of Statistics of China. China Statistical Yearbook (2016). Beijing: China Statistics Press; 2016.
  • Wang Q, Jin C. Quantitative measurement of economic development imbalance among urban agglomerations in China. J Quantitative Tech Economics. 2018;35(11):77–94. doi:10.13653/j.cnki.jqte.2018.11.005
  • Guo Y, Liu Q. Comprehensive evaluation on regional differences of medical and health development level in China. Chine J Health Statistics. 2016;33(2):251–253.
  • Li X, Cao X, Guo M, Xie M, Liu X. Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017. Br Med J. 2020;368. doi:10.1136/bmj.m234
  • Haldun A. User’s guide to correlation coefficients. Turkish J Em Med. 2018;18(3):91. doi:10.1016/j.tjem.2018.08.001
  • Liu Y, Liu J, Liu S, et al. Death and impact of life expectancy attributable to smoking in China, 2013. Chine J Epidemiol. 2017;38(08):1005–1010. doi:10.3760/cma.j.issn.0254-6450.2017.08.002
  • Yin P, Cai Y, Liu J, et al. Disease burden attributable to household air pollution in 1990 and 2013 in China. Chine J Preventive Med. 2017;51(01):53–57. doi:10.3760/cma.j.issn.0253-9624.2017.01.011
  • Fang L, Bao H, Wang B, et al. Survey and analyses of rate of spirometry examination in adults aged 40 years and older in China,2014. Chine J Epidemiol. 2018;39(05):593–599. doi:10.3760/cma.j.issn.0254-6450.2018.05.010
  • Lv X, Cong S, Fan J, et al. Analyses of the rate of spirometry examination and its related factors in chronic obstructive pulmonary disease patients aged 40 years or older in China, 2014–2015. Chine J Epidemiol. 2020;(05):672–677. doi:10.3760/cma.j.cn112338-20200122-00054
  • Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5(2):020415. doi:10.7189/jogh.05-020415
  • Fang X, Wang X, Bai C. COPD in China: the burden and importance of proper management. Chest. 2011;139(4):920–929. doi:10.1378/chest.10-1393
  • Silverman EK, Weiss ST, Drazen JM. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162(6):2152. doi:10.1164/ajrccm.162.6.2003112
  • Ezzati M, Horwitz MEM, Thomas DSK, et al. Altitude, life expectancy and mortality from ischaemic heart disease, stroke, COPD and cancers: national population-based analysis of US counties. J Epidemiol Community Health. 2012;66(7):e17. doi:10.1136/jech.2010.112938
  • Guan W, Ge R. Effects of plateau environment on respiratory diseases. Natl Med China. 2015;95(30):2491–2493. doi:10.3760/cma.j.issn.0376-2491.2015.30.022
  • Guo Y, Xing Z, Shan G, et al. Prevalence and risk factors for COPD at high altitude: a large cross-sectional survey of subjects living between 2100–4700 m above sea level. Front Med. 2020:7. doi:10.3389/fmed.2020.581763
  • Bai G, He F, Hu Y. Death causes of residents in Tibet autonomous region. Disease Surveillance. 2011;26(01):55–57. doi:10.3784/j.issn.1003-9961.2011.01.017
  • General Office of the State Council. Healthy China Action (2019–2030); 2019. [cited May 5, 2021.]; Available from: http://www.gov.cn/xinwen/2019-07/15/content_5409694.htm. Accessed October 20, 2021.